Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
DLHCX Fund | USD 21.35 0.13 0.61% |
Slightly above 54% of Delaware Healthcare's investor base is interested to short. The analysis of overall sentiment of trading Delaware Healthcare Fund mutual fund suggests that many investors are impartial at this time. Delaware Healthcare's investing sentiment can be driven by a variety of factors including economic data, Delaware Healthcare's earnings reports, geopolitical events, and overall market trends.
Delaware |
Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration approval as a treatment for obstructive sleep apnea among adults with obesity.
Read at finance.yahoo.com
Delaware Healthcare Fundamental Analysis
We analyze Delaware Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Delaware Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Delaware Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Position Weight
Cash Position Weight Comparative Analysis
Delaware Healthcare is currently under evaluation in cash position weight among similar funds. Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Delaware Healthcare Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Delaware Healthcare mutual fund to make a market-neutral strategy. Peer analysis of Delaware Healthcare could also be used in its relative valuation, which is a method of valuing Delaware Healthcare by comparing valuation metrics with similar companies.
Peers
Delaware Healthcare Related Equities
PNRCX | Jennison Natural | 0.07 |
| ||
SMAPX | Salient Mlp | 0.28 |
| ||
AIWEX | World Energy | 0.33 |
| ||
TMCLX | Transamerica Mlp | 0.45 |
| ||
ALTEX | Firsthand Alternative | 0.69 |
|
Other Information on Investing in Delaware Mutual Fund
Delaware Healthcare financial ratios help investors to determine whether Delaware Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Delaware with respect to the benefits of owning Delaware Healthcare security.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |